kefanyangjob
The Biotech Beat
The Biotech Beat is your go-to podcast for decoding the science shaping our future. From synthetic biology and gene editing to groundbreaking therapeutics and biotech startups, we break down complex topics into engaging conversations. Whether you’re a curious mind, a student, or a scientist on the go, join us each week as we explore the innovations, challenges, and people behind the world of biotechnology.
No dejes de visitar la web del podcast y apoyar a su creador: kefanyangjob.podbean.com
Autor
kefanyangjob
Categoría
Web del podcast
Último episodio
17 de ago. de 2025
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Instálala gratis
Android casi 10 M de descargas · valoración de 4,7+
iOS muy pronto
Episodios
Monoclonal Antibodies: Engineering the Future of Precision Medicine 17.08.2025 15:53
A scientific discussion touches upon the potential evolution of viruses to become integrated into the host genome, while another academic source specifically addresses the structural basis of antibody-antigen recognition, emphasizing the contributions of both hypervariable and constant regions to binding specificity and effector functions.
AIntibody: AI/ML Antibody Discovery Design Challenge 06.08.2025 14:33
Tune in to explore AIntibody, an innovative AI/ML benchmarking competition for antibody discovery. Like CASP, it validates computational models by having participants submit antibody sequences for experimental wet lab testing. This initiative provides clarity on the real-world capabilities and limitations of AI/ML in therapeutic antibody engineering.
Podcasts similares
Escucha el podcast The Biotech Beat en Replaio
Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos
